Concepedia

Mary Nallin

MN

Statistics

Publications

6

Citations

225

H-Index

6

Active since

1977

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Mary Nallin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biochemistry, life sciences, and microbial metabolism.

Publications per year

1977–1995

6

Publications

6

Biosynthetic origin of the carbon skeleton and oxygen atoms of the avermectins

David E. Cane, Tzyy Chyau Liang, Louis A. Kaplan et al. · Journal of the American Chemical Society · 1983 · 79 citations

, , +5

The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor.

Claude Dufresne, Kenneth E. Wilson, Deborah L. Zink et al. · Tetrahedron · 1992 · 58 citations

, , +8

Demethylavermectins. Biosynthesis, isolation and characterization.

Marvin D. Schulman, Delia Valentino, Otto D. Hensens et al. · The Journal of Antibiotics · 1985 · 29 citations · Full text

, , +4

L-755,805, a new polyketide endothelin binding inhibitor from an actinomycete

Y. K. TONY LAM, Otto D. Hensens, Gregory L. Helms et al. · Tetrahedron Letters · 1995 · 21 citations

, , +8

Avermectin B2 O-methyltransferase activity in "Streptomyces avermitilis" mutants that produce increased amounts of the avermectins

Marvin D. Schulman, Delia Valentino, Mary Nallin et al. · Antimicrobial Agents and Chemotherapy · 1986 · 20 citations

, , +14

1–5 of 6